Taamil, Ana Jean R.

HRN: 28-71-83  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/23/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/23/2026
03/30/2026
IV
2300mg
Q 6 Hours
PCAP-C
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: